首页> 外文期刊>Diabetic medicine: A journal of the British Diabetic Association >Reply to Retnakaran R, Shah BR. Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet Med 2009; 26: 474-477.
【24h】

Reply to Retnakaran R, Shah BR. Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet Med 2009; 26: 474-477.

机译:回复给Retnakaran R,Shah BR。妊娠期葡萄糖筛查试验异常和年轻女性未来患糖尿病的风险。糖尿病杂志2009; 26:474-477。

获取原文
获取原文并翻译 | 示例
           

摘要

I am not convinced from the study by Renakaran and Shah [1] claiming that an abnormal gestational diabetes mellitus (GDM) test during pregnancy followed by a normal oral glucose tolerance test (OGTT) provides prognostic information that could not be obtained rather more simply. The authors created a matched cohort based upon age, region, socio-economic status and year of delivery. However, they did not match for body mass index (BMI), nor for non-pregnant abdominal circumference. I wonder if Renakaren and Shah could explore their database to determine if the women who developed Type 2 diabetes mellitus (T2DM) during the study were more overweight and had a greater abdominal circumference, and whether these risk factors were similar in the cohort and the matched population? As the 'number needed to test' is 303 to identify one patient who will go on to develop diabetes; one wonders if information such as abdominal circumference and BMI would be practical indicators of risk.
机译:Renakaran和Shah [1]的研究并没有使我确信怀孕期间的异常妊娠糖尿病(GDM)测试以及随后的正常口服葡萄糖耐量测试(OGTT)提供的预后信息无法更简单地获得,我对此并没有信心。作者根据年龄,地区,社会经济地位和分娩年份创建了一个匹配的队列。但是,它们与体重指数(BMI)或非妊娠腹围均不匹配。我想知道Renakaren和Shah是否可以探索他们的数据库来确定研究期间患2型糖尿病(T2DM)的妇女是否超重,腹围更大,以及这些风险因素在队列研究中是否相似?人口?由于“需要测试的数量”是303,以识别一名将继续患糖尿病的患者;人们想知道诸如腹围和BMI之类的信息是否可以作为危险的实际指标。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号